Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
1.66% Pomegranate Powder 150 mg
It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
Jest on obecnie badany jako potencjalne leczenie dla niektrych rodzajw nowotworw, w tym raka piersi i biaaczki
doi: 10.1038/sj.ijo.0802206 65
US$ 27.44
US$ 27.62
US$ 22.20
US$ 23.70
US$ 24.04
US$ 23.47
US$ 29.27
